Yale Nobel Laureate Honored with Connecticut Medal of Science
News Apr 22, 2013
Best known for his research into ribosomal proteins, the building blocks of all life, Steitz is also renowned for his work with dozens of student mentees who became scientific leaders, themselves.
Steitz co-founded New Haven-based Rib-X Pharmaceuticals in 2001 to develop new classes of antibiotics. Today, the company has 45 full-time employees.
In addition to the 2009 Nobel Prize in Chemistry, Steitz has received a Gairdner International Award, a Keio Medical Science Prize, the AAAS Newcomb Cleveland Prize, and many other honors.
Interaction Mechanism for 'Boiled Noodle' Proteins IdentifiedNews
Even unstructured proteins can bind together with incredible strength using electrostatic attraction, a new study suggests.READ MORE
Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain TherapeuticsNews
The new Swiss company will operate in Lugano and Barcelona under the scientific management of Minoryx co-founder Dr Xavier Barril.READ MORE